Basic Science

2: Development of models of Neurofibromatosis 2 (NF2) loss in kidney cancer of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC)

5: SETD2 loss promotes macrophage infiltration and metastasis in RCC

6: ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma

7: Targeting BCL-XL Hyperdependency in Kidney Cancer

8: Investigating the role of Human endogenous retrovirus group E (HERV-E) in clear cell Renal Cell Carcinoma (ccRCC) through hypoxia and interferon signaling pathway

9: The impact of Diabetes Mellitus on survival in patients surgically treated for Renal Cell Carcinoma: A Danish cohort study

10: Dissecting Tumor Metabolism Crosstalk in Renal Cell Cancer

11: Intravital multiphoton microscopy of bone metastatic renal cell carcinoma

12: Epithelial to mesenchymal transition (EMT) and PD-1/PD-L1 signaling provide reciprocal feedback in renal cell carcinoma progression with implications for immunotherapy response

13: Spatially resolved single cell transcriptomic analysis of matched primary and metastatic lesions in sarcomatoid renal cell carcinoma reveals insights to tumor biology

14: The antihistamine terfenadine inhibits TFE3 dimerization and tumor growth in translocation renal cell carcinoma models.

15: Therapeutic targeting of mitochondrial metabolism by P2X4 receptor inhibition and amino acid restriction in renal carcinoma models

16: Mitochondrial Fatty Acid Synthesis Gene Mecr Regulates CD4+ and CD8+ T Cell Function

17: VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis